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There are more possible vaccination interventions tomitigate the adverse health consequences of populations in
crises than ever before, but recent reviews suggest delivering these vaccines has been fraught with difficulty. The
decision to implement vaccination interventions in crises remains, more often than not, an exercise in satisficing.
The sparse credible epidemiologic and effectiveness data in populations affected by crises contributes greatly to
decision-making difficulty, as do the limits of vaccine presentations, formulations and storage. Political consid-
erations and lack of decision-making guidance contribute further. Moving forward requires sound effectiveness
studies to help ensure that decision-making is based to the degree possible on substance.
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As of the end of 2013, there were about 10.4 million refugees,
28.8 million displaced persons and about 1 billion persons living
in 40 so-designated ‘fragile states’, as well as almost 400 country-
level natural disasters, affecting almost 300 million people.1 In
addition, particularly in Sub-Saharan Africa, many populations
remain in a permanent state of vulnerability.
Fortunately, at no time in history have there been asmany pos-
sible vaccination interventions tomitigate the adverse health con-
sequences of populations in crises. Unfortunately, recent reviews
suggest delivering these vaccines has been fraught with difficulty,
with vaccines either underused or inappropriately used interven-
tions in crises.2 Identifying the genesis of these difficulties is prob-
lematic andmultifactorial. The decision to implement vaccination
interventions in crises remains, more often than not, an exercise in
satisficing.3 Satisficing can be summarized as the tendency to
select the first option that meets a given need and/or selecting
the safest decision given the knowledge available and/or failing
to consider hidden aspects of the problem from an overarching
view; thereby, failing to live up to the explicit and sometimes im-
plicit objective of reducing morbidity and, therefore, mortality. Of
the multitude of reasons that satisficing remains prevalent, four
aspects contribute to the predominance of this heuristic.
First, the sparse credible epidemiologic and effectiveness data
in populations affected by crises contributes greatly.4,5 As devel-
opment and rollout of new and underutilized vaccines continues,
we will certainly understand more about the epidemiology of
vaccine preventable disease. Studies addressing vaccine response
in vulnerable populations, for example acutely malnourished chil-
dren, should be encouraged. Further, exploring the underperform-
ance of oral vaccines in vulnerable populations remains an
important issue. In the meantime, the lack of epidemiologic and
immunologic data with which to center the discussion makes
decision-making all the more difficult in crises.
Second, the limited presentations, formulations requiring mul-
tiple doses at short intervals and storage requirements of vaccines
also encourage satisficing. Although presentation and formula-
tion are of the utmost importance, the cold chain and storage
issues present, arguably, one of the greatest barriers.6,7 The cold
chain is important to reduce the potential risk of vaccine degrad-
ation by either exposure to high or low temperature and was
designed to ensure simplicity by following a single set of rules
for all vaccines.8 However, it involves high costs and logistical
requirements, which are increasing with the introduction of new
bulkier vaccines. This can especially be an issue in crises where
cold chain equipment and infrastructure is most likely lacking or
insufficient. The need to conduct several campaigns within a
short time-frame and the inability to keep vaccines at the recom-
mended storage conditions may restrict the decision-making
horizon as to which vaccination interventions are implemented.
Third, in terms of political considerations, the highly politicized
nature of epidemics, with clear and real difficulties to declare epi-
demics, has led often to hesitancy to implement vaccination
interventions in response to epidemics.9 Declaration of epidemics
entails an implicit recognition of a failure of control and prevention
programs. Debates around the appropriate timing of their use,
when is it too late to implement a vaccination intervention in
response to an epidemic or during a crises, the effectiveness of
the vaccines and the risk of vaccination interventions potentially
diverting resources away from case management interventions
all aggravate decision-making.
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Fourth, adding to the tendency to satisfice is the lack of
decision-making guidance. At its essence, it is often forgotten
that vaccination in crises is delicate. It is a multiple class
problem with many facets and there is not an expert panel in
the world that can provide overarching guidance applicable to
all possible scenarios. Satisficing is especially problematic and in-
efficient when the stakes are high and time is limited. Clear guid-
ance on how to evaluate the risk of vaccine preventable diseases
and how to consider the potential effectiveness of interventions is
essential to support decision-makers. Being able to demand the
right type and amount of relief at the right time can best be
done when those advocating for it, within or outside the corridors
of power, are able to present their reasoning in a scientifically
sound fashion; thus, focusing the discussion on substantive
matters and reducing the scope for dismissing the evidence.
WHO recently convened a working group to address this issue
and the results of this work provide at least a framework with
which to base decisions.10 Use of this framework can help over-
come the often ingrained response of having what agencies
know how to do, or using only those vaccines that are available.
This framework is a step in the right direction to ensure that the
needs take supremacy over what can be delivered, but more
work is need to ensure that additional work follows from this pro-
posed framework.
There are several ways forward that can help to reduce
satisfice-based decision-making for vaccination intervention in
crises. First, funding and supporting sound epidemiological docu-
mentation projects and effectiveness studies would help ensure
that decision-making is based to the degree possible on sub-
stance. With robust data and effective high coverage interven-
tions, political difficulties may not disappear but are minimized.
Second, with respect to the vaccines themselves, continuing the
debate around the use of adjuvants to reach successful immun-
ization with a single dose of vaccine, and use of vaccine in a con-
trolled temperature chain, would simplify vaccination activities
and, consequently, the decision to protect populations from iden-
tified risks. Adapted presentations, formulations and storage
requirements can be achieved by engaging with manufacturers
prior to licensure and WHO prequalification, and promoting
research that considers the different contexts where vaccines
are used. Third, ways forward with respect to de-politicization of
epidemics are less clear. Additional efforts need to bemade to en-
courage epidemic declaration and call for interventions without
political penalty. Fourth, the new WHO framework needs to be
evaluated to assess to which degree it reduces satisficed-based
decisions.
Finally, depending on the agency and funder, the decision to
implement an intervention during a crisis may not always be
taken in consultation with the population or with those delivering
the intervention. Ensuring that the populations who will benefit
from the interventions are included in the decision process may
introduce complexity, but lies at the crux of ensuring vaccines
reach those that need them most.
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